ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-34089

An unauthenticated remote code execution vulnerability exists in Remote for Mac, a macOS remote control utility developed by Aexol Studio, in versions up to and including 2025.7.

Published Jul 3, 2025 · catalog updated May 15, 2026 · Aexol Studio Remote for Mac

Check if you run it

No confirmed exploitation is on record for CVE-2025-34089. EPSS is 2.35%. Act only if a listed version of Aexol Studio Remote for Mac is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
2.35%
Remediation
Vendor / distro source
Affected products
vendor Aexol Studio Remote for Mac 0 ≤2025.7

An unauthenticated remote code execution vulnerability exists in Remote for Mac, a macOS remote control utility developed by Aexol Studio, in versions up to and including 2025.7. When the application is configured with authentication disabled (i.e., the "Allow unknown devices" option is enabled), the /api/executeScript endpoint is exposed without access control. This allows unauthenticated remote attackers to inject arbitrary AppleScript payloads via the X-Script HTTP header, resulting in code execution using do shell script. Successful exploitation grants attackers the ability to run arbitrar

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Aexol Studio Remote for Mac 0 ≤2025.70 ≤2025.7

How to fix CVE-2025-34089

  • Recommended remediation

    A vendor or distribution source is linked. Check that advisory for patch availability; this catalog does not invent fix status.

  • Official advisories

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-34089. EPSS is 2.35%. Act only if a listed version of Aexol Studio Remote for Mac is installed.

Which versions are affected?

Compare what you have installed with Aexol Studio Remote for Mac 0 ≤2025.7 0 ≤2025.7. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 2.35%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jul 3, 2025 · EUVD

    Detected

    An unauthenticated remote code execution vulnerability exists in Remote for Mac, a macOS remote control utility developed by Aexol Studio, in versions up to and including 2025.7. When the application is configured with authentication disabled (i.e., the "Allow unknown devices" option is enabled), the /api/executeScript endpoint is exposed without access control. This allows unauthenticated remote

  2. May 15, 2026 · EUVD

    Updated

    An unauthenticated remote code execution vulnerability exists in Remote for Mac, a macOS remote control utility developed by Aexol Studio, in versions up to and including 2025.7. When the application is configured with authentication disabled (i.e., the "Allow unknown devices" option is enabled), the /api/executeScript endpoint is exposed without access control. This allows unauthenticated remote

Sources

  • EUVDVulnerability recordEUVD-2025-19900

    An unauthenticated remote code execution vulnerability exists in Remote for Mac, a macOS remote control utility developed by Aexol Studio, in versions up to and including 2025.7. When the application is configured with authentication disabled (i.e., the "Allow unknown devices" op

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog May 15, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.